Dexamethasone Treatment for Covid-19, a Curious Precedent Highlighting a Regulatory Gap

Título

Dexamethasone Treatment for Covid-19, a Curious Precedent Highlighting a Regulatory Gap

Autor

Filippo Drago, Lucia Gozzo, Laura Longo, Daniela Cristina Vitale, Filippo Drago, Filippo Drago

Fecha

2020

Materia

covid-19, drug repurposing, Off-label, Dexamethasone, European Medicines Agency

Identificador

10.3389/fphar.2020.621934

Fuente

Epidemiology and Health

Editor

Korean Society of Epidemiology

Cobertura

Therapeutics. Pharmacology

Archivos

https://socictopen.socict.org/files/to_import/pdfs/91f66390cf849d52dc0b60f66ab71577.pdf

Colección

Citación

Filippo Drago, Lucia Gozzo, Laura Longo, Daniela Cristina Vitale, Filippo Drago, Filippo Drago, “Dexamethasone Treatment for Covid-19, a Curious Precedent Highlighting a Regulatory Gap,” SOCICT Open, consulta 18 de abril de 2026, https://socictopen.socict.org/items/show/9042.

Formatos de Salida

Position: 16076 (19 views)